CDKN2A and MC1R analysis in amelanotic and pigmented melanoma

Paola Ghiorzo, Lorenza Pastorino, Maria A. Pizzichetta, Riccardo Bono, Paola Queirolo, Renato Talamini, Giorgio Annessi, William Bruno, Sabina Nasti, Sara Gargiulo, Linda Battistuzzi, Maria C. Sini, Giuseppe Palmieri, Giovanna Bianchi Scarrà

Research output: Contribution to journalArticlepeer-review


Amelanotic melanoma (AM) is a rare subtype of melanoma with little or no clinically visible pigment; it is more difficult to diagnose than pigmented melanoma (PM), and has a worse prognosis. In the attempt to find a genetic explanation for the distinction between AM and PM, we conducted a case-case study, matching AM and PM patients, and testing them for germline mutations in high- (p16INK4A, p14ARF, CDK4) and low-penetrance (MC1R) melanoma susceptibility genes. Similar CDKN2A mutations were found in both sets of melanomas. A p14ARF splice germline mutation was detected for the first time in an Italian family with AM. This rare mutation, which has been described only once previously, may be involved in predisposition to the amelanotic phenotype in combination with germline MC1R variants and coordinate somatic expression of pigmentation genes and their regulators.

Original languageEnglish
Pages (from-to)142-145
Number of pages4
JournalMelanoma Research
Issue number3
Publication statusPublished - Jun 2009

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Dermatology


Dive into the research topics of 'CDKN2A and MC1R analysis in amelanotic and pigmented melanoma'. Together they form a unique fingerprint.

Cite this